Document Detail

Albendazole kinetics in patients with echinococcosis: delayed absorption and impaired elimination in cholestasis.
MedLine Citation:
PMID:  2373135     Owner:  NLM     Status:  MEDLINE    
The pharmacokinetics of albendazole and its main metabolite, albendazole sulphoxide, have been examined after giving a single oral dose of 200 mg albendazole to 19 patients with either Echinococcus multilocularis or E. granulosus, 5 of whom had significant extrahepatic obstruction due to the underlying disease. The AUC of albendazole sulphoxide was increased in the latter patients (mean 122 mumols.h.l-1 compared to 17 mumols.h.l-1 in the non-obstructed group). Obstructed patients had delayed absorption, ka averaging 0.39 compared to 1.41 h-1 in non-obstructed patients. The corresponding elimination rate constant, ke was also prolonged, averaging 0.041 and 0.13 h-1 in the two groups, respectively. Four patients were restudied after complete or partial resolution of the cholestasis. The pharmacokinetic parameters in them had returned towards values comparable to those in the non-obstructed patients.
J Cotting; T Zeugin; U Steiger; J Reichen
Related Documents :
15168215 - Cpap-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome.
22433945 - Amiodarone and the thyroid: a 2012 update.
6814315 - Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acut...
14580925 - Efficacy of the novel phosphodiesterase-4 inhibitor bay 19-8004 on lung function and ai...
18371535 - Therapies for acute heart failure in patients with reduced kidney function: a community...
23104195 - Is curve direction correlated with the dominant side of tonsillar ectopia and side of s...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  38     ISSN:  0031-6970     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  1990  
Date Detail:
Created Date:  1990-08-29     Completed Date:  1990-08-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  605-8     Citation Subset:  IM    
Department of Clinical Pharmacology, University of Berne, Switzerland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albendazole / analogs & derivatives,  metabolism,  pharmacokinetics*
Cholestasis / metabolism*
Echinococcosis / metabolism*
Intestinal Absorption
Middle Aged
Reg. No./Substance:
54029-12-8/albendazole sulfoxide; 54965-21-8/Albendazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Single- and multiple-dose pharmacokinetics of R-(-)-and S-(+)-prenylamine in man.
Next Document:  Pharmacokinetics and endocrine effects of terguride in healthy subjects.